Insider Trading Activity Epizyme, Inc. (NASDAQ:EPZM) – Insider Sold 15,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Epizyme, Inc. (NASDAQ:EPZM)

Peter Tai-Ching Ho , Insider of Epizyme, Inc. (NASDAQ:EPZM) reportedly Sold 15,000 shares of the company’s stock at an average price of 13.44 for a total transaction amount of $201,600.00 SEC Form

Insider Trading History For Epizyme, Inc. (NASDAQ:EPZM)

  • On 6/5/2013 Venture Fund I L.P. Astellas, Major Shareholder, bought 15,333 with an average share price of $15.00 per share and the total transaction amounting to $229,995.00.View SEC Filing
  • On 6/5/2013 David M Mott, Director, bought 400,000 with an average share price of $15.00 per share and the total transaction amounting to $6,000,000.00.View SEC Filing
  • On 11/15/2013 M James Barrett, major shareholder, bought 406,500 with an average share price of $19.68 per share and the total transaction amounting to $7,999,920.00.View SEC Filing
  • On 12/2/2013 Robert Copeland, EVP, sold 5,000 with an average share price of $20.70 per share and the total transaction amounting to $103,500.00.View SEC Filing
  • On 12/16/2013 Robert Copeland, EVP, sold 4,600 with an average share price of $21.21 per share and the total transaction amounting to $97,566.00.View SEC Filing
  • On 1/6/2014 Jason Rhodes, CFO, sold 10,000 with an average share price of $20.19 per share and the total transaction amounting to $201,900.00.View SEC Filing
  • On 2/10/2014 Celgene European Investment Co, major shareholder, bought 340,000 with an average share price of $29.25 per share and the total transaction amounting to $9,945,000.00.View SEC Filing

    • Analyst Ratings For Epizyme, Inc. (NASDAQ:EPZM)
    These are 10 Buy Ratings .
    The current consensus rating for Epizyme, Inc. (NASDAQ:EPZM) is Buy (Score: 3.00) with a consensus target price of $24.86 , a potential (102.09% upside)

    Analyst Ratings History For Epizyme, Inc. (NASDAQ:EPZM)

    • On 12/22/2015 SunTrust Banks, Inc. Initiated Coverage of rating Buy with a price target of $21.00
    • On 6/20/2016 Mizuho Reiterated Rating Buy with a price target of $18.00
    • On 11/6/2016 JMP Securities Reiterated Rating Buy
    • On 4/13/2017 CIBC Reiterated Rating Outperform to Outperform
    • On 5/18/2017 Wedbush Reiterated Rating Outperform with a price target of $24.00
    • On 6/7/2017 HC Wainwright Reiterated Rating Buy with a price target of $25.00
    • On 6/7/2017 Cowen and Company Reiterated Rating Buy

    Recent Trading Activity for Epizyme, Inc. (NASDAQ:EPZM)
    Shares of Epizyme, Inc. closed the previous trading session at 12.30 down -0.35 -2.77% with 333,271 shares trading hands.